Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Fox Chase Faculty to Present Educational Webinar on Lung Cancer Research
PHILADELPHIA (June 5, 2020)—Fox Chase faculty members will be hosting a virtual education presentation next Tuesday, June 9, from 5:30 pm to 6 pm, titled “From Bench to Bedside – Lung Cancer Treatments.”
During the event, Fox Chase faculty will discuss scientific research into lung cancer and how it is impacting future care and treatments for patients. The panel will discuss how research can help identify who is at increased risk for cancer, help increase survival, and provide a better future for those diagnosed with lung cancer. The researchers will also discuss how cancer cells become resistant to treatment.
Patients, caregivers, and health professionals are invited to the webinar with the following Fox Chase faculty:
- Johnathan Whetstine, PhD, professor, endowed chair, and program leader for the Cancer Epigenetics Program
- Margie L. Clapper, PhD, professor, endowed chair, and co-leader of the Cancer Prevention and Control Program
- Hossein Borghaei, DO, MS, professor, endowed chair, and chief of thoracic oncology in the Department of Hematology/Oncology
The free webinar is presented by the American Lung Association and Fox Chase Cancer Center. To RSVP for the event and to submit questions, contact Felice.Kelem@Lung.org by noon on Monday, June 8. All who register will receive a meeting link to connect via video call. For additional questions, call 610-235-2513.
The event is being held in conjunction with the LUNG FORCE Walk, taking place virtually now through Saturday, June 20. Fox Chase has a team helping raise funds to support research, advocacy, and education for lung cancer and other lung diseases. These efforts can be supported through the team page.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427